Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MANE will rise by +24.23% over the next 2 Weeks and hit $129.07 by Tuesday, May 26, 2026. In that time frame, MANE's share price is expected to range between $121.00 and $136.81.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 26, 2026 | 121.00 | 129.07 | 136.81 |
| May 25, 2026 | 119.77 | 127.59 | 136.02 |
| May 22, 2026 | 114.72 | 122.69 | 130.43 |
| May 21, 2026 | 109.76 | 117.26 | 125.72 |
| May 20, 2026 | 110.36 | 118.25 | 125.81 |
| May 19, 2026 | 110.21 | 117.92 | 125.46 |
| May 18, 2026 | 108.78 | 116.43 | 124.37 |
| May 15, 2026 | 104.00 | 111.54 | 119.28 |
| May 14, 2026 | 98.16 | 106.11 | 114.41 |
| May 13, 2026 | 99.88 | 107.10 | 114.89 |
MANE shares rose +3.75% in Wednesday, May 13, 2026's trading session, rising from a previous close of $103.90 to move at $107.80. The stock demonstrated notable intraday movement (see MANE's key stats for a full breakdown), fluctuating between $102.70 and $110.13, a +7.23% trading range. While recent weeks have seen some volatility, MANE has managed to secure a +4.56% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 560.45K shares changing hands, 190.96K more than the previous session. This amounted to $60.42M in total market activity.
Will MANE Continue Its Upward Trend?
According to analyst ratings and projections for MANE, Veradermics, Incorporated shares are anticipated to increase by +21.20%, potentially reaching $136.81 per share by May 26, 2026. Short-term technical indicators for MANE currently suggest a bullish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the MANE stock forecast, now is a good time to buy MANE stock because its current trading price is -16.48% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on MANE covering social and institutional perspectives.
MANE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MANE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 64.13% to 66.01%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 66.40%, suggests strong medium-term momentum. Insights into MANE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Veradermics Short-Term Forecasts
MANE Forecast For Next 5 Days
Our algorithm anticipates Veradermics (MANE) stock could hit $99.00 by May 20, 2026. This represents a -8.16% fall from today's price, following a - change over the past five days.
MANE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Veradermics, Incorporated (MANE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $106.69, which would mean a -1.03% decrease from the current price of $107.80. Projections for this period range from a high of $136.20 to a low of $80.94.
MANE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Veradermics's price over the next three months point to a rise. MANE stock is expected to peak at $2,091.43 on May 29, 2026 before potentially dipping to $0.00 on Jun 23, 2026. On average, MANE is likely to trade around $400.08 in the coming 90 days.
Veradermics Stock Forecast 2025
Based on our predictive models, Veradermics (MANE) is expected to trade between $0.00 and $2,296.94 throughout 2026. This would result in an average price of $412.45, potentially offering investors a +282.61% return from current levels.
Veradermics, Incorporated Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Veradermics, Incorporated (MANE) is positioned to show a strong performance in May 2026. The price is predicted to move between $97.90 and $2091.43, settling at an average of $876.59. This could translate to a +713.16% gain.
June 2026
Based on current market signals, Veradermics, Incorporated is projected to trend june 2026. We forecast a trading range from $0.00 to $2030.71, with a likely average price of $395.37. Investors could expect a potential return of +266.76%.
July 2026
Our predictive algorithms indicate Veradermics, Incorporated stock may see a shift in July 2026. The expected range spans $194.13–$221.32, with an average target of $207.40. This represents a positive outlook and a possible gain of +92.39%.
August 2026
Analyzing established trends, Veradermics, Incorporated looks set to move in August 2026. Projections place the stock between $211.75 and $228.96, averaging around $221.47. This suggests a +105.45% gain from current levels.
September 2026
Market indicators suggest Veradermics, Incorporated could experience notable changes during September 2026. Prices could fluctuate within $220.62 to $273.77, with a midpoint forecast of $241.97. The stock might deliver a +124.46% gain.
October 2026
Forecasting for October 2026, models estimate that Veradermics, Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $254.87 and $2296.94, averaging $960.23. This signals a positive trajectory with potential returns around +790.75%.
November 2026
According to our latest forecast models, Veradermics, Incorporated (MANE) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $1117.93, settling at an average of $221.65. This could translate to a +105.61% gain.
December 2026
Based on current market signals, Veradermics, Incorporated is projected to trend december 2026. We forecast a trading range from $346.45 to $365.98, with a likely average price of $359.15. Investors could expect a potential return of +233.16%.
January 2027
Our predictive algorithms indicate Veradermics, Incorporated stock may see a shift in January 2027. The expected range spans $364.62–$381.09, with an average target of $374.53. This represents a positive outlook and a possible gain of +247.43%.
February 2027
Analyzing established trends, Veradermics, Incorporated looks set to move in February 2027. Projections place the stock between $373.73 and $425.78, averaging around $395.87. This suggests a +267.23% gain from current levels.
March 2027
Market indicators suggest Veradermics, Incorporated could experience notable changes during March 2027. Prices could fluctuate within $402.46 to $2449.24, with a midpoint forecast of $1108.18. The stock might deliver a +928.00% gain.
April 2027
Forecasting for April 2027, models estimate that Veradermics, Incorporated may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1270.15, averaging $315.93. This signals a positive trajectory with potential returns around +193.07%.
May 2027
According to our latest forecast models, Veradermics, Incorporated (MANE) is positioned to show a strong performance in May 2027. The price is predicted to move between $499.70 and $516.65, settling at an average of $509.28. This could translate to a +372.43% gain.
MANE's history of dividends and stock splits also plays a role in long-term investor confidence.

